Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1420-1423

  Petraglia, Felice ^a   Florio, Pasquale ^b   Benedetto, Chiara ^c   Marozio, Luca ^c   Di Blasio, Anna Maria ^d   Ticconi, Carlo ^e   Piccione, Emilio ^e   Luisi, Stefano ^b   Genazzani, Andrea R ^b   Vale, Wyle ^f  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRESSIN; CORTICOTROPIN; PROSTAGLANDIN; UROCORTIN;

ARTICLE; CHROMOSOMAL LOCALIZATION; FEEDING BEHAVIOR; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; MOLECULAR CLONING; MUSCLE ISOMETRIC CONTRACTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RECEPTOR AFFINITY; RECEPTOR BINDING; TROPHOBLAST; UTERUS CONTRACTILITY;

EID: 0033307044     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.4.5585     Document Type: Article

References (30)

1. Cloning and characterization of human urocortin
2. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
3. Urocortin expression in human pituitary gland and pituitary adenoma
4. Human placenta and fetal membranes express human urocortin mRNA and peptide
5. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): A novel mechanism for elevating free CRF levels in human brain
6. Labelling of CRF1 and CKF2 receptors using the novel radioligand' [3H]-urocortin
7. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
8. Cardiac inotropic actions of urocortin in conscious sheep
9. Urocortin' a corticotropin-releasing factor-related mammalian peptide inhibits edema due to thermal injury in rats
10. Peptide signalling in human placenta: Autocrine, paracrine, and endocrine mechanisms
11. The placental corticotropin-releasing hormone-adrenocorticotrophin axis
12. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta
13. Effect of corticotrophin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes
14. Corticotropin-releasing hormone-induced vasodilation in the human fetal placental circulation
15. CRH increases prostaglandin F2 in human myometrium in vitro
16. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy
17. Identification and characterization of a corticotrophin-releasing hormone in human placenta
18. Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta
19. Effect of corticotropin-releasing factor binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro
20. Activin A, corticotropin-releasing factor and prostaglandin F2α increase immunoreactive oxytocin release from cultured human placental cells
21. Eicosanoid production in itrauterine tissues before and after labor in short-term tissue culture
22. Effects of glucocorticoids and progesterone on prostaglandin E2 and leukotriene B4 release by human fetal membranes at term gestation
23. Release of arachidonic acid metabolites by human fetal membranes: Interrelationship between leukotriene B4 and prostaglandin E2
24. Cellular localization of corticotrophin-releasing hormone in the human placenta, fetal membranes and decidua
25. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues
26. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin
27. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1α (CRH-1α) and the CRH-C variant receptor
28. Urocortin is a potent inducer of skin mast cell activation and vasodilation: Implications for stress-induced atopic diseases
29. Corticotropin-releasing hormone-induced vasodilation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway
30. Effects of restricting utero-placental blood flow on concentrations of corticotropin-releasing hormone, adrenocorticotrophin, cortisol, and prostaglandin E2 in the sheep fetus during late pregnancy